German industry criticises proposed revisions to Pharmaceutical Act - Update
This article was originally published in SRA
The German pharmaceutical industry has criticised some of the government’s proposed amendments to the Pharmaceutical Act, which would oblige them to supply wholesalers1,2. The aim of the health ministry is to guarantee the provision of medicines to the public as quickly as possible via wholesalers and pharmaceutical manufacturers. Faraz Kermani reports.